INCAS - Integrated Care of Asthma in Switzerland

Sponsor

Cantonal Hosptal, Baselland (Other)

Overall Status

Completed

CT.gov ID

NCT02425293

Collaborator

(none)

223

Enrollment

Arms

Duration (Months)

Study Details

Study Description

Brief Summary

The aim of this study was to investigate the effect of standardized patient education on asthma control. In collaboration with two health insurance companies, pharmacists and pneumologists, patients with asthma were recruited. They completed the "Asthma Control Test (ACT)" and the "Patient Assessment of Chronic Illness Care (PACIC 5A)" questionnaire to assess asthma control and patients' satisfaction with the health care service they received. Additionally, patients were offered the possibility to participate in a patient education seminar run by the Swiss lung leagues or the Swiss allergy centre (aha!). After one year, patients were asked to complete the questionnaires again. Comparisons of intraindividual changes and differences regarding ACT and PACIC 5A between patients with and without patient education were made.

Condition or Disease	Intervention/Treatment	Phase
Asthma	Behavioral: asthma patient education	N/A

Study Design

Study Type:

Interventional

Actual Enrollment :

223 participants

Allocation:

Non-Randomized

Intervention Model:

Parallel Assignment

Masking:

None (Open Label)

Primary Purpose:

Supportive Care

Study Start Date :

Jun 1, 2012

Actual Primary Completion Date :

Dec 1, 2014

Actual Study Completion Date :

Dec 1, 2014

Arms and Interventions

Arm	Intervention/Treatment
Experimental: Intervention Patients participating in a patient education seminar	Behavioral: asthma patient education
No Intervention: Control Patients not participating in a patient education seminar

Arm

Intervention/Treatment

Experimental: Intervention

Patients participating in a patient education seminar

Behavioral: asthma patient education

No Intervention: Control

Patients not participating in a patient education seminar

Outcome Measures

Primary Outcome Measures

Comparison of patient characteristics between the intervention and the control group [baseline]
Comparison of asthma control between the intervention and the control group [baseline]
Asthma control is measured using the Asthma Control Test (ACT).
Comparison of patient satisfaction between the intervention and the control group [baseline]
Patient satisfaction is measured using the Patient Assessment of Chronic Illness Care (PACIC 5A) questionnaire.

Secondary Outcome Measures

Comparison of asthma control at baseline and after one year in the intervention group. [baseline and follow up (after one year)]
Analysis of change in asthma control (using the Asthma Control Test (ACT)) in the intervention group from baseline to follow up (after one year).
Comparison of asthma control at baseline and after one year in the control group. [baseline and follow up (after one year)]
Analysis of change in asthma control (using the Asthma Control Test (ACT)) in the control group from baseline to follow up (after one year).
Comparison of patient satisfaction at baseline and after one year in the intervention group. [baseline and follow up (after one year)]
Analysis of change in patient satisfaction (using the PACIC 5A questionnaire) in the intervention group from baseline to follow up (after one year).
Comparison of patient satisfaction at baseline and after one year in the control group. [baseline and follow up (after one year)]
Analysis of change in patient satisfaction (using the PACIC 5A questionnaire) in the control group from baseline to follow up (after one year).

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years to 59 Years

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

patients with clinical asthma diagnosis
written informed consent

Exclusion Criteria:

inadequate knowledge of the German language
subjects with severe diseases with life expectancy under one year
subjects with known Chronic Obstructive Pulmonary Disease (COPD)

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

Cantonal Hosptal, Baselland

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Prof. Dr. Jörg Leuppi, Prof. Dr. med., Cantonal Hosptal, Baselland

ClinicalTrials.gov Identifier:

NCT02425293

Other Study ID Numbers:

274/11

First Posted:

Apr 23, 2015

Last Update Posted:

Apr 23, 2015

Last Verified:

Apr 1, 2015

Additional relevant MeSH terms:

Asthma

Study Results

No Results Posted as of Apr 23, 2015